221 results found.

HIV Positive Youth That Are Newly Engaged in Care Clinical Trial using Project ACCEPT; HEALTH

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - Recruiting 16 years to 24 years.
- Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care.
Project ACCEPT; HEALTH

HIV Infections Clinical Trial using Current ARV medications; Current TB medications; Current hormonal contraceptive medications

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting N/A or older.
- Pharmacokinetic Properties of Antiretroviral and Related Drugs During Pregnancy and Postpartum.
Current ARV medications; Current TB medications; Current hormonal contraceptive medications

Cardiovascular Disease, or HIV Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Biomarkers of Inflammation, Coagulation, and Endothelial Function in HIV-Infected Adults.

AIDS Associated Nephropathy, Focal Glomerulosclerosis, or HIV Inf Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Genetic Markers for Focal Segmental Glomerulosclerosis.

HIV, HIV Infections, or Pregnancy Clinical Trial using TMC114 (darunavir); ritonavir; TMC125 (etravirine); TMC278 (rilpivirine)

Janssen Scientific Affairs, LLC - Recruiting 18 years or older.
- A Single Arm, Open Label Study to Assess the Pharmacokinetics of Darunavir/Ritonavir and/or Etravirine and Rilpivirine in HIV-1 Infected Pregnant Women.
TMC114 (darunavir); ritonavir; TMC125 (etravirine); TMC278 (rilpivirine)

HIV-1 Infection Clinical Trial using Raltegravir

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- A Non-interventional Cohort Study for the Assessment of the Efficacy of RALTEGRAVIR 400 mg Administered Twice Daily in Combination With Other Antiretroviral Drugs to Treat Infection With the Human Immunodeficiency Virus 1 (HIV-1) in Adults and Aging Patients (ò 50 Years) Under Conditions That Are Representative of the Nationwide Treatment of HIV-positive Patients in Germany.
Raltegravir

Staphylococcal Infection Clinical Trial using XF-73 in 4% Klucelr gel; XF-73 in 2% Klucelr gel; Placebo in 4% Klucelr gel

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 45 years.
- A Two-Part Phase I Study to Establish and Compare the Safety and Local Tolerability of Two Nasal Formulations of XF-73 for Decolonization of Staphylococcus Aureus: A Previously Investigated 0.5 mg/g Viscosified Gel Formulation Versus a Modified Formulation.
XF-73 in 4% Klucelr gel; XF-73 in 2% Klucelr gel; Placebo in 4% Klucelr gel

HIV Infections Clinical Trial using Methotrexate (MTX); Placebo; Folic acid

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 40 years or older.
- Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection.
Methotrexate (MTX); Placebo; Folic acid

Kaposi's Sarcoma, HIV+, HIV Positive, or AIDS Clinical Trial using aldoxorubicin

CytRx - Recruiting 18 years or older.
- An Open-Label Pilot Phase 2 Study to Investigate Efficacy, Safety, and Intratumoral Kinetics of ALDOXORUBICIN in HIV-Infected Patients With Kaposi's Sarcoma.
aldoxorubicin

Tuberculosis, or HIV Infections Clinical Trial using Rifapentine (RPT); Isoniazid (INH); Pyridoxine (Vitamin B6)

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 13 years or older.
- Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection.
Rifapentine (RPT); Isoniazid (INH); Pyridoxine (Vitamin B6)

Human Immunodeficiency Virus-type 1 Infection Clinical Trial using Rilpivirine; Efavirenz; Tenofovir disoproxil fumarate; Emtricitabine

Janssen-Cilag International NV - Recruiting 18 years or older.
- A Phase 3b, Randomized, Open-label Clinical Study to Demonstrate Non-inferiority in Virologic Response Rates of HIV-1 RNA Suppression <400 Copies/mL of TDF/FTC/RPV Versus TDF/FTC/EFV in First-line Antiretroviral NNRTI-based Suppressed Patients. Switching At Low HIV-1 RNA Into Fixed Dose Combinations (SALIF).
Rilpivirine; Efavirenz; Tenofovir disoproxil fumarate; Emtricitabine

HIV Infections Clinical Trial using Dolutegravir (DTG) tablet formulation; DTG oral pediatric granules taken as suspension or granules

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting N/A to 17 years.
- Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of GSK1349572, a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and Adolescents.
Dolutegravir (DTG) tablet formulation; DTG oral pediatric granules taken as suspension or granules

HIV Infection, or Unspecified Adult Solid Tumor, Protocol Specifi Clinical Trial using cabozantinib-s-malate; pharmacological study; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase I Trial of Cabozantinib (XL184) for Advanced Solid Tumors in Persons With HIV Infection.
cabozantinib-s-malate; pharmacological study; laboratory biomarker analysis

HIV, Salivary Gland Disease, or Benign Lymphoepithelial Lesion Clinical Trial using Ciprofloxacin; Placebo

University of North Carolina, Chapel Hill - Recruiting 18 years or older.
- BK Virus in Salivary Gland Disease.
Ciprofloxacin; Placebo

Human Immunodeficiency Virus (HIV) Clinical Trial using Maraviroc

ViiV Healthcare - Recruiting 2 years to 18 years.
- An Open-Label, Multicenter, Multiple-Dose Pharmacokinetic, Safety And Efficacy Trial Of Maraviroc In Combination With Optimized Background Therapy For The Treatment Of Antiretroviral-Experienced CCR5-Tropic HIV-1 Infected Children 2 - <18 Years Of Age.
Maraviroc

Human Immunodeficiency Virus Clinical Trial using Maraviroc along with an optimized background antiretroviral drug regimen; Optimized background antiretroviral drug regimen without maraviroc

ViiV Healthcare - Recruiting 18 years or older.
- An International, Multicenter, Prospective Observational Study Of The Safety Of Maraviroc Used With Optimized Background Therapy In Treatment-Experienced HIV-1 Infected Patients.
Maraviroc along with an optimized background antiretroviral drug regimen; Optimized background antiretroviral drug regimen without maraviroc

HIV-1 Infection Clinical Trial

University of North Carolina, Chapel Hill - Recruiting 18 years or older.
- CID 1213 - Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women After Switching to Fixed Dose Combination of Rilpivirine, Emtricitabine and Tenofovir DF.

HIV Infection Clinical Trial using Vitamin D3 (cholecalciferol); Placebo

Harvard School of Public Health - Recruiting 18 years or older.
- Trial of Vitamin D in HIV Progression.
Vitamin D3 (cholecalciferol); Placebo

Risk Behavior, Medication Adherence, or HIV Clinical Trial using 3H+ (Holistic Health for HIV); HHRP+ (Holistic Health Recovery Program)

University of Connecticut - Recruiting 18 years or older.
- Secondary HIV Prevention and Adherence Among HIV-infected Drug Users.
3H+ (Holistic Health for HIV); HHRP+ (Holistic Health Recovery Program)

HIV-1, HIV Infections, or Acquired Immunodeficiency Syndrome Clinical Trial using E/C/F/TAF; DRV; Pre-existing ARV regimen

Gilead Sciences - Recruiting 18 years or older.
- A Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults.
E/C/F/TAF; DRV; Pre-existing ARV regimen

Healthy, or HIV Clinical Trial using 1 mg/kg, single dose IV administration of 3BNC117; 3 mg/kg, single dose IV administration of 3BNC117; 10 mg/kg, single dose IV administration of 3BNC117

Rockefeller University - Recruiting 18 years to 65 years.
- A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers.
1 mg/kg, single dose IV administration of 3BNC117; 3 mg/kg, single dose IV administration of 3BNC117; 10 mg/kg, single dose IV administration of 3BNC117

HIV, Acquired Immunodeficiency Syndrome, or Cardiovascular Diseas Clinical Trial using Exercise Program; Control Group

University of Miami - Recruiting N/A to 25 years.
- Atherosclerotic Risk and Response to Exercise Intervention in HIV+ Children.
Exercise Program; Control Group

HIV-1 Infection Clinical Trial using BMS-955176; Placebo matching with BMS-955176; Atazanavir; Ritonavir; Tenofovir; Emtricitabine

Bristol-Myers Squibb - Recruiting 18 years to 55 years.
- Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacodynamics, Safety and Pharmacokinetics of BMS-955176 (Double-Blinded) and BMS-955176 With Atazanavir +/- Ritonavir (Open-Labeled) in HIV-1 Infected Subjects.
BMS-955176; Placebo matching with BMS-955176; Atazanavir; Ritonavir; Tenofovir; Emtricitabine

HIV Infection Clinical Trial using Maraviroc; Emtricitabine; Tenofovir disoproxil fumarate; Maraviroc placebo; Emtricitabine placebo; Tenofovir disoproxil fumarate placebo

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years or older.
- A Phase II Randomized, Double-Blind, Study of the Safety and Tolerability of Maraviroc (MVC), Maraviroc + Emtricitabine (MVC+FTC), Maraviroc + Tenofovir Disoproxil Fumarate (MVC+TDF), or Tenofovir Disoproxil Fumarate + Emtricitabine (TDF+FTC) For Pre-Exposure Prophylaxis (PrEP) To Prevent HIV Transmission in At-Risk Men Who Have Sex With Men and in At-Risk Women.
Maraviroc; Emtricitabine; Tenofovir disoproxil fumarate; Maraviroc placebo; Emtricitabine placebo; Tenofovir disoproxil fumarate placebo

Acquired Immune Deficiency Syndrome (AIDS), or HIV Infections Clinical Trial using E/C/F/TAF

Gilead Sciences - Recruiting 12 years to 17 years.
- A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents.
E/C/F/TAF

HIV Infection Clinical Trial using Tenofovir, Emtricitabine, Lopinavir/r; Tenofovir, Emtricitabine, Raltegravir

Hospital Clinic of Barcelona - Recruiting 18 years or older.
- Open Randomized Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir.
Tenofovir, Emtricitabine, Lopinavir/r; Tenofovir, Emtricitabine, Raltegravir

HIV Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients With CD4 Count Less Than or Equal to 100 Cells/microL Who Are Initiating Antiretroviral Therapy.

HIV-1 Clinical Trial using EFV/FTC/TDF + Losartan; EFV/FTC/TDF; FTC/TDF + MK-0518; FTC/TDF+MK-0518+Losartan

Hospital Clinic of Barcelona - Recruiting 18 years or older.
- .
EFV/FTC/TDF + Losartan; EFV/FTC/TDF; FTC/TDF + MK-0518; FTC/TDF+MK-0518+Losartan

Sexually Transmitted Diseases, Unsafe Sex, or Substance-Related D Clinical Trial using Connect II; TAU

Columbia University - Recruiting 18 years or older.
- Couple HIV Prevention for Drug Involved Male Offenders: An Effectiveness Trial.
Connect II; TAU

HIV Infection Clinical Trial using Tenofovir, emtricitabine, maraviroc; Tenofovir, emtricitabine, lopinavir/r

Hospital Clinic of Barcelona - Recruiting 18 years or older.
- Open Randomized Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: TENOFOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC.
Tenofovir, emtricitabine, maraviroc; Tenofovir, emtricitabine, lopinavir/r

HIV Clinical Trial using antiretroviral therapy; cell phone reminders; contingency management for adherence

University of Connecticut Health Center - Recruiting 18 years or older.
- Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus.
antiretroviral therapy; cell phone reminders; contingency management for adherence

Acquired Immunodeficiency, or Neurocognitive Disorders Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 61 years.
- Screening and Recruitment for HIV-associated Neurocognitive Disorders (HAND) Studies and an Evaluation of HIV-associated Neurocognitive Disorders in Virologically Controlled Patients With CD4 Nadir of Less Than 200 Cells Per mm (3).

HIV, or AIDS Clinical Trial using individualized Texting for Adherence Building (iTAB); Psychoeducation

University of California, San Diego - Recruiting 18 years or older.
- Personalized Text Messages to Improve ART Adherence in HIV+ Methamphetamine Users.
individualized Texting for Adherence Building (iTAB); Psychoeducation

Anal Cancer, Nonneoplastic Condition, Penile Cancer, or Precancer Clinical Trial using quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine; laboratory biomarker analysis

AIDS Malignancy Clinical Trials Consortium - Recruiting 13 years to 26 years.
- AMC-072: Protective Effect of Quadrivalent Vaccine in Young HIV-Positive Males Who Have Sex With Males.
quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine; laboratory biomarker analysis

HIV Infections Clinical Trial using 'Kallunk oxide (Immunotherapy) '

Traditional Alternative Medicine Research, India - Recruiting 8 years to 45 years.
- Phase III Clinical Studies on Traditional CAM Therapy in the Treatment of HIV/AIDS.
'Kallunk oxide (Immunotherapy) '

HIV, Atrial Fibrillation, or Venous Thromboembolism Clinical Trial using Ritonavir; Cobicistat

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 70 years.
- The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Pharmacodynamics in Healthy Volunteers.
Ritonavir; Cobicistat

HIV, Respiratory Infections, Fungal Pneumonia, Viral Pneumonia, o Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections.

HIV, or Therapeutic Vaccine Clinical Trial using HIV-1 Multiantigen pDNA Vaccine; Human IL-12 pDNA; In Vivo Electroporation using the TriGri; rVSVIN HIV Gag Vaccine; Placebo

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 65 years.
- A Phase I Randomized, Double-Blind, Placebo-Controlled Study of a Multi-Antigen DNA Vaccine Prime Delivered by In Vivo Electroporation, rVSV Booster Vaccine in HIV-Infected Patients Who Began Antiretroviral Therapy During Acute/Early Infection.
HIV-1 Multiantigen pDNA Vaccine; Human IL-12 pDNA; In Vivo Electroporation using the TriGri; rVSVIN HIV Gag Vaccine; Placebo

HIV Infections Clinical Trial using Cell Transfer

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Immunologic and Virologic Response in HIV Infected Progressors After Infusion of Lymphocytes From HIV Infected 'Elite' Long-Term Non-Progressors.
Cell Transfer

HIV Infection, or Kaposi's Sarcoma Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer.

HIV Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-Infected Patients.

HIV Infections, AIDS, or Opportunistic Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection.

Cancer, or HIV Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 7 years to 21 years.
- The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory, Pilot Study.

HIV Infection, or Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 7 years to 17 years.
- Psychological Benefits of a Normalized Camping Experience for Children With Cancer.

Hepatitis C, or Human Immunodeficiency Virus Clinical Trial using Boceprevir

Erasmus Medical Center - Recruiting 18 years or older.
- Efficacy of 12 Week Boceprevir in Addition to Standard of Care Therapy Consisting of Peginterferon-alpha-2b and Ribavirin for the Treatment of Acute HCV Genotype 1 in HIV Co-infected Patients. A Proof of Concept Feasibility Clinical Trial..
Boceprevir

Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficie Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 14 years or older.
- Characterization and Management of Patients With HIV-1 Infection Who Experience Virologic Failure Despite Combination Antiretroviral Therapy.

Focus of Study is to Increase STI Knowledge Clinical Trial using Adapted Many Men, Many Voices (3MV) group level intervention; A group-based HIV/STI prevention intervention for women who have sex with women

University of Toronto - Recruiting 18 years or older.
- Pilot-testing a Group-level Intervention to Reduce Risk for Sexual Transmission of HIV/STIs Among Lesbian, Bisexual and Queer Women and Other Women Who Have Sex With Women in Calgary and Toronto.
Adapted Many Men, Many Voices (3MV) group level intervention; A group-based HIV/STI prevention intervention for women who have sex with women

Tuberculosis, HIV, or IRIS Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Transcriptional Signature of HIV And TB Co-Infection.

HIV Infections, Central Nervous System Neoplasms, or Neurofibroma Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Analysis of Stored Data Collected From Individuals Administered Neurobehavioral Assessments on IRB-Approved Protocols.

HIV, or Disclosure Clinical Trial using Amagugu Counseling Intervention

University of KwaZulu - Recruiting 16 years or older.
- Maternal HIV Disclosure to School Children: RCT of Family-based Intervention (Amagugu).
Amagugu Counseling Intervention

Acquired Immune Deficiency Syndrome (AIDS), or HIV Infections Clinical Trial using Elvitegravir; RTV-boosted PI

Gilead Sciences - Recruiting N/A to 17 years.
- A Phase 2/3 Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG)Administered With a Background-Regimen (BR) Containing a Ritonavir-Boosted Protease Inhibitor (PI/r) in HIV-1 Infected, Antiretroviral Treatment-Experienced Pediatric Subjects.
Elvitegravir; RTV-boosted PI

HIV, or Sexually Transmitted Infections Clinical Trial using Latino STYLE

University of South Florida - Recruiting 14 years or older.
- A Randomized Controlled Trial of Family-Based HIV Prevention for Latino Youth.
Latino STYLE

HIV Clinical Trial using Truvada (once daily tablet containing 300mg tenofovir disoproxil (TDF) and 200mg of emtricitabine (FTC)

Medical Research Council - Recruiting 18 years or older.
- Pre-exposure Option for Reducing HIV in the UK: an Open-label Randomisation to Immediate or Deferred Daily Truvada for HIV Negative Gay Men.(PROUD).
Truvada (once daily tablet containing 300mg tenofovir disoproxil (TDF) and 200mg of emtricitabine (FTC)

AIDS Clinical Trial using Blood collection; GSK HIV vaccine 732462

GlaxoSmithKline - Recruiting 18 years to 56 years.
- Long-term Follow-up of Participants From Studies Evaluating the HIV Vaccine 732462.
Blood collection; GSK HIV vaccine 732462

Tuberculosis Clinical Trial using DAR-901; BCG; Sterile saline

Dartmouth-Hitchcock Medical Center - Recruiting 18 years to 65 years.
- A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose, Dose-Ranging Study of the Safety and Immunogenicity of DAR-901, a Killed, Non-Tuberculous Mycobacterial Vaccine, in HIV-negative and HIV-positive Adults Who Have Previously Received BCG.
DAR-901; BCG; Sterile saline

Pneumonia, Pneumococcal Infection, or Pathogen Resistance Clinical Trial using Colistimethate (Colistin)Sodium-Intravenous; Colistimethate (Colistin)Sodium-Aerosolized

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 45 years.
- A Phase 1, Open-Labeled Study of the Safety, Tolerability and Pharmacokinetics of Aerosolized Colistimethate Sodium After Multiple Doses Administered Separately or in Combination With Intravenous Colistimethate Sodium in Healthy Adults.
Colistimethate (Colistin)Sodium-Intravenous; Colistimethate (Colistin)Sodium-Aerosolized

HIV Infections Clinical Trial using MK-1439; Efavirenz; TRUVADAr

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- Multicenter, Double-Blind, Randomized, 2-Part, Dose Ranging Study to Compare the Safety, and Antiretroviral Activity of MK-1439 Plus TRUVADA Versus Efavirenz Plus TRUVADA in Antiretroviral Treatment-Naive, HIV-1 Infected Patients.
MK-1439; Efavirenz; TRUVADAr

Healthy Adult Females Clinical Trial using Tenofovir; Maraviroc

University of North Carolina, Chapel Hill - Recruiting 18 years to 49 years.
- A Feasibility Study to Assess Protection of Vaginal and Cervical Tissues From Ex-Vivo HIV-1 Challenge Following Oral Administration of Maraviroc and Tenofovir.
Tenofovir; Maraviroc

HIV Infection Clinical Trial using Hydroxychloroquine

St Stephens Aids Trust - Recruiting 18 years to 65 years.
- The Immunological Impact of Adding Hydroxychloroquine in Patients With Discordant CD4+ Cell Responses to Suppressive HAART: A Phase I Pilot Study..
Hydroxychloroquine

Hepatitis B Virus, or HIV Clinical Trial using Standard of care

University of North Carolina, Chapel Hill - Recruiting 18 years or older.
- CIDRZ-1220 Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa: a Collaborative Multi-country Prospective Cohort Analysis for International Epidemiologic Databases to Evaluate AIDS- Southern Africa (HIV/HBV-coinfection in IeDEA-SA).
Standard of care

Cancer, HIV Infection, or Skin Disease Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI) Center for Cancer Research (CCR) Clinical Protocols.

Influenza Clinical Trial using Amantadine, Ribavirin, Oseltamivir; Oseltamivir

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years or older.
- A Randomized Double-Blind Phase 2 Study Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications.
Amantadine, Ribavirin, Oseltamivir; Oseltamivir

Opiate Dependence Clinical Trial using Vivitrol; Naltrexone (oral); BDRC; Medical Management

Yale University - Recruiting 18 years to 65 years.
- Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia.
Vivitrol; Naltrexone (oral); BDRC; Medical Management

Parkinson's Disease, or HIV Infections Clinical Trial

KineMed - Recruiting 18 years or older.
- Cellular and Molecular Kinetics of Cerebrospinal Fluid (CSF) Using Heavy Water Labeling Method: A Study of Healthy Controls, CNS HIV Infection, Parkinson's Disease and Other Neurodegenerative Diseases.

Hepatitis C, Chronic, or Human Immunodeficiency Virus Clinical Trial using DAA against HCV

Valme University Hospital - Recruiting 18 years or older.
- Security and Efficacy of Triple Therapy Including Direct-Acting Antivirals Against Chronic Hepatitis C Infection In HIV-Coinfected Patients In Real-Life Conditions: The Prospective HEPAVIR Cohort..
DAA against HCV

Papillomavirus Infections, or HIV Infections Clinical Trial using Oral swabs for HPV-typing and high-risk HPV-determination

Deutsche Luft und Raumfahrt - Recruiting 18 years or older.
- Incidence, Prevalence, Spectrum of HPV-types, and Viral Load Determination of High-risk Human Papillomavirus Infection of the Oral Cavity in HIV-infected Men Who Have Sex With Men.
Oral swabs for HPV-typing and high-risk HPV-determination

HIV Infections, Papillomavirus Infections, or Anal Intraepithelia Clinical Trial using Smear and biopsy testing for HPV-types and viral load

Deutsche Luft und Raumfahrt - Recruiting 18 years or older.
- Evaluation of Viral Load Determination and Other Biomarkers of High Risk HPV-Types as a Marker for Progression of Perianal HPV-infections in HIV-positive Men Who Have Sex With Men.
Smear and biopsy testing for HPV-types and viral load

HIV Infection Clinical Trial using 3MV; PCC; Emtricitabine/tenofovir (FTC/TDF (Truvadar))

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - Recruiting 15 years to 17 years.
- Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States.
3MV; PCC; Emtricitabine/tenofovir (FTC/TDF (Truvadar))

HIV, COPD, Emphysema, or Smoking Clinical Trial using Genetic: Examination of the interaction of HIV directly on the small airway epithelium

Weill Medical College of Cornell University - Recruiting 18 years or older.
- HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium.
Genetic: Examination of the interaction of HIV directly on the small airway epithelium

Clinician Attitudes About PrEP Clinical Trial

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - Recruiting N/A or older.
- Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention.

HIV, COPD, Chronic Obstructive Pulmonary Disease, or Smoking Clinical Trial using Examination of the interaction of HIV directly on the small airway epithelium

Weill Medical College of Cornell University - Recruiting 18 years or older.
- HIV-related Accelerated Aging of the Airway Epithelium.
Examination of the interaction of HIV directly on the small airway epithelium

HIV, Patient Adherence, or Mobile Technology Clinical Trial using Text Messages; Appointment Reminders

University of California, San Francisco - Recruiting 18 years or older.
- Seek Test Treat Retain Strategies Leveraging Mobile Health Technologies.
Text Messages; Appointment Reminders

Acquired Immune Deficiency Syndrome (AIDS), or HIV Infections Clinical Trial using ATV; DRV; Cobicistat; Background regimen

Gilead Sciences - Recruiting 3 Months to 17 years.
- A Phase 2/3, Multicenter, Open-label, Multicohort, Two-Part Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co), Administered With Background Regimen (BR) in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects.
ATV; DRV; Cobicistat; Background regimen

Heart Diseases, or HIV Clinical Trial

University Hospital, Bonn - Recruiting 18 years or older.
- Myocardial T1-mapping and T1-derived Extracellular Volume Fraction (ECV) in HIV-infection Patients With Chronic High and Low CD4+ Counts and in a Healthy Control Group.

HIV, or Hepatitis B Clinical Trial using Tenofovir/lamivudine/lopinavir-ritonavir; Zidovudine/lamivudine/lopinavir-ritonavir

Centers for Disease Control and Prevention - Recruiting 20 years or older.
- Maternal Tenofovir-containing Combination Drug Regimen During the Second and Third Trimesters of Pregnancy for Prevention of Mother-to-child Transmission of HIV and HBV in HIV-HBV Co-infected Mothers.
Tenofovir/lamivudine/lopinavir-ritonavir; Zidovudine/lamivudine/lopinavir-ritonavir

HIV Clinical Trial using PATCH; SRS

University of Maryland - Recruiting 21 years to 60 years.
- Increasing Motivation for Antiretroviral Therapy Initiation: A Pilot Intervention.
PATCH; SRS

Risk Behavior, or Mental Health Impairment Clinical Trial using Trauma-Focused Cognitive Behavioral Therapy; Psychosocial Counseling

Johns Hopkins Bloomberg School of Public Health - Recruiting 13 years to 17 years.
- Randomized Controlled Trial of Ways to Improve OVC HIV Prevention and Well-being.
Trauma-Focused Cognitive Behavioral Therapy; Psychosocial Counseling

HIV+ Clinical Trial using Oral naltrexone; Naltrexone implant

University of Pennsylvania - Recruiting 18 years or older.
- Adherence to HIV Therapy in Heroin Addicts: Oral vs. Extended Release Naltrexone.
Oral naltrexone; Naltrexone implant

HIV Clinical Trial

Fundacion SEIMC-GESIDA - Recruiting N/A or older.
- Retrospective Study to Determine the Incidence of Bone Fractures in HIV-infected Patients in Spain.

Inflammation, Macrophage Infiltration, or Cardiovascular Disease Clinical Trial using Sitagliptin; Placebo

Washington University School of Medicine - Recruiting 18 years to 65 years.
- A Double Blind, Randomized, Placebo Controlled Study to Determine the Physiological Effectiveness of Januvia (100 mg/d) for Reducing Inflammation and Increasing Endothelial Progenitor Cell Number in Human Immunodeficiency Virus (HIV) Infected Men and Women With Insulin Resistance and Central Adiposity..
Sitagliptin; Placebo

Social Anxiety, or Substance Use Clinical Trial using Reduction of social anxiety & substance use in gay/bi men

Ryerson University - Recruiting 18 years or older.
- An HIV Prevention Intervention for HIV-negative Men Who Have Sex With Men Via Reduction of Social Anxiety and Substance Use in Sexual Situations.
Reduction of social anxiety & substance use in gay/bi men

HIV Infection Clinical Trial using Micronutrients and antioxidants; Multivitamins and minerals

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- A Randomized Control Clinical Trial Of Micronutrient & Antioxidant Supplementation in Persons With Untreated HIV Infection.
Micronutrients and antioxidants; Multivitamins and minerals

Human Immunodeficiency Virus (HIV), or Acquired Immune Deficiency Clinical Trial

Columbia University - Recruiting 1 Month to 12 years.
- Enhanced Surveillance and 2 Year Outcomes of Children Enrolled on Antiretroviral Therapy (ART) in Public Health Facilities in the Eastern Cape Province, South Africa.

Tuberculosis Diagnosis, or HIV Clinical Trial

University of North Carolina, Chapel Hill - Recruiting N/A or older.
- CIDRZ 1201 - Optimizing Clinical Outcomes in HIV-Infected Adults & Children Using Xpert MTB/RIF in Zambia.

Adult Grade III Lymphomatoid Granulomatosis, AIDS-related Diffuse Clinical Trial using doxorubicin hydrochloride; vincristine sulfate; vorinostat; prednisone; rituximab; cyclophosphamide; etoposide; laboratory biomarker analysis; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy With Rituximab in HIV-Related B-cell Non-Hodgkin's Lymphoma.
doxorubicin hydrochloride; vincristine sulfate; vorinostat; prednisone; rituximab; cyclophosphamide; etoposide; laboratory biomarker analysis; pharmacological study

HIV Infection, Monoclonal Antibody, Human, HIV Antibodies, VRC01 Clinical Trial using VRC-HIVMAB060-00-AB

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 50 years.
- VRC 602: A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIV MAB060-00-AB (VRC01),Administered Intravenously or Subcutaneously to Healthy Adults.
VRC-HIVMAB060-00-AB

HIV/AIDS Clinical Trial using omega 3 fatty acids

Coordinaci¢n de Investigaci¢n en Salud, Mexico - Recruiting 20 years to 60 years.
- Effect of Omega 3 Fatty Acids on Oxidative Stress in Seropositive HIV Patients.
omega 3 fatty acids

Influenza, Human Clinical Trial using Oseltamivir; Oseltamivir Placebo

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 64 years.
- A Randomized Double-Blind Study Comparing Oseltamivir Versus Placebo for the Treatment of Influenza in Low Risk Adults.
Oseltamivir; Oseltamivir Placebo

Opiate Dependence Clinical Trial using Behavioral Drug and HIV Risk Reduction Counseling; Educational Counseling; Treatment as Usual

Yale University - Recruiting 20 years to 65 years.
- Behavioral Drug and HIV Risk Reduction Counseling With MMT in China.
Behavioral Drug and HIV Risk Reduction Counseling; Educational Counseling; Treatment as Usual

Atherosclerosis Clinical Trial

University of California, San Francisco - Recruiting 18 years to 65 years.
- Immunologic and Inflammatory Factors and Cardiovascular Risk in Patients With HIV Infection or Autoimmune Diseases.

HIV Infection Clinical Trial

Merck Sharp & Dohme Corp. - Recruiting 3 years or older.
- Re-examination Study for General Drug Use to Assess the Safety and Efficacy Profile of STOCRIN in Usual Practice.

HIV-1 Infection Clinical Trial

Gen-Probe, Incorporated - Recruiting 15 years or older.
- Collection of Plasma Samples From Human Immunodeficiency Virus (HIV) Type 1 (HIV-1) Infected Individuals for the Clinical Evaluation of the Aptima HIV-1 Quant Dx Assay.

HIV-1 Infection Clinical Trial using Vorinostat

University of North Carolina, Chapel Hill - Recruiting 18 years to 65 years.
- A Phase I/II Investigation of the Effect of Vorinostat (VOR) on HIV RNA Expression in the Resting CD4+ T Cells of HIV-Infected Patients Receiving Stable Antiretroviral Therapy.
Vorinostat

HIV Infection, Cardiovascular Disease, or Inflammation Clinical Trial

University of California, San Francisco - Recruiting 40 years to 80 years.
- The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk.

HIV Clinical Trial using VAC-3S

InnaVirVax - Recruiting 18 years to 60 years.
- Assessment of the Therapeutic Properties of the VAC-3S Immunoprotective Vaccine When Combined With Standard Antiretroviral Therapy (ART) in the Course of HIV-1 Infection. A European, Randomized, Double Blind Placebo-controlled Phase II Study.
VAC-3S

HIV Infection Clinical Trial using Bruthas Project; Standard HIV Testing and Counseling

University of California, San Francisco - Recruiting 18 years to 65 years.
- A Randomized Controlled Trial of the Bruthas Project.
Bruthas Project; Standard HIV Testing and Counseling

School Adjustment, or Foster Care Disruptions Clinical Trial using LINKS

Oregon Social Learning Center - Recruiting 9 years to 13 years.
- Foster Teens' Risk During Transition: Preventing Drug Use, HIV, & School Problems.
LINKS

HIV Infection Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Reproductive Fluids in HIV-Infected and HIV-Uninfected Volunteers.

HIV-1 Infection Clinical Trial using Part A: lenalidomide dose escalation; Part B: lenalidomide; Part B: lenalidomide placebo

Bionor Immuno AS - Recruiting 18 years to 55 years.
- A Double-blind Placebo Controlled Immunogenicity Study of Vacc-4x + Lenalidomide Versus Vacc-4x With an Initial Open-label Dose Escalation Assessment of Lenalidomide in HIV-1-infected Subjects on Antiretroviral Therapy (ART)..
Part A: lenalidomide dose escalation; Part B: lenalidomide; Part B: lenalidomide placebo

HIV Clinical Trial using POC CD4 Testing; CD4 Referral; Lay Counselor Follow-up; Clinic Accompaniment; Clinic Referral; SMS Reminder; Circumcision Promotion; POC VL; Laboratory based VL assay

University of Washington - Recruiting 16 years or older.
- An Evaluation of Strategies to Increase Testing and Linkages of HIV Positive Individuals to Care and HIV Negative Men to Male Circumcision in Sub-Saharan Africa.
POC CD4 Testing; CD4 Referral; Lay Counselor Follow-up; Clinic Accompaniment; Clinic Referral; SMS Reminder; Circumcision Promotion; POC VL; Laboratory based VL assay

Healthy Volunteer, or HIV Vaccine Clinical Trial using Ad4-mgag; Ad4-EnvC150

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 49 years.
- Phase I Study of Safety and Immunogenicity of Ad4-HIV Vaccine Vectors in Healthy Volunteers.
Ad4-mgag; Ad4-EnvC150

HIV, Childhood, Natural History, Cardiac, or ART Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 10 years or older.
- Clinical Outcomes in Persons With HIV Acquired Early in Life.

Human Immunodeficiency Virus (HIV) Clinical Trial using Sexual Health Counseling; Enhanced Adherence Intervention; PrEP Information (Active Control); Standard of Care Adherence Support (Active Control)

Hunter College - Recruiting 18 years or older.
- Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting.
Sexual Health Counseling; Enhanced Adherence Intervention; PrEP Information (Active Control); Standard of Care Adherence Support (Active Control)

Human Immunodeficiency Virus, or Neurocognitive Impairment Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 25 years to 55 years.
- Neurovascular Magnetic Resonance Imaging in the Assessment of HIV-Associated Neurocognitive Disorders.

Hepatitis C, or HIV Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications.

Immunodeficiency, Mycobacterial Infection, or Opportunistic Infec Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma.

Hepatitis, HIV, or Liver Cancer Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- The Natural History of Liver Disease in a Cohort of Participants With Hepatitis B and/or Hepatitis C With or Without HIV Infection.

HIV Infection Clinical Trial using atazanavir 300mg boosted with ritonavir 50 mg

Ottawa Hospital Research Institute - Recruiting 18 years to 70 years.
- Microboosting of Atazanavir 300 mg With 50 mg Versus 100 mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study.
atazanavir 300mg boosted with ritonavir 50 mg

Human Immunodeficiency Virus (HIV) Clinical Trial using Enhanced Treatment Support (ETS)

Karolinska Institutet - Recruiting N/A to 12 years.
- A Randomized Controlled Trial to Assess the Effect of Group Peer Support to Children With HIV in Relation to Adherence, Virological Treatment Failure as Well as Physical Development.
Enhanced Treatment Support (ETS)

Acquired Immunodeficiency Syndrome, or HIV Infections Clinical Trial using EVG/COBI/FTC/TDF

Gilead Sciences - Recruiting 12 years to 17 years.
- A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents.
EVG/COBI/FTC/TDF

HIV, or Smoking Cessation Clinical Trial using Nicotine Replacement Therapy (NRT); Varenicline; HIV Tailored Quit Smoking Counseling

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers.
Nicotine Replacement Therapy (NRT); Varenicline; HIV Tailored Quit Smoking Counseling

Healthy Clinical Trial using TMC278, Long acting (LA)

Janssen Research & Development, LLC - Recruiting 18 years to 45 years.
- Phase 1 Open Label Safety, Acceptability, Pharmacokinetic and ex Vivo Pharmacodynamic Study of TMC278 Long Acting (LA) Administered Intramuscularly to HIV-1 Seronegative Individuals.
TMC278, Long acting (LA)

HIV, or ART Clinical Trial using Comprehensive intervention group

National Center for AIDS/STD Control and Prevention, China CDC - Recruiting 18 years to 59 years.
- A Cluster-randomized Controlled Trial of Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission.
Comprehensive intervention group

HIV Infections Clinical Trial

Boehringer Ingelheim Pharmaceuticals - Recruiting 18 years to 64 years.
- Observational Study Assessing the Safety, Efficacy and Treatment Adherence of Nevirapine Extended Release (Combined With Other Antiretroviral Drugs) in HIV Infected Patients in Daily Clinical Practice.

HIV Clinical Trial using Atripla

Fred Hutchinson Cancer Research Center - Recruiting 18 years or older.
- HIV Testing and Treatment to Prevent Onward HIV Transmission Among MSM and Transgender Women in Lima, Peru.
Atripla

Tuberculosis Clinical Trial using rifapentine (M000473); EFZ EMT TDF

Sanofi - Recruiting 18 years to 55 years.
- An Open-label, Non-randomized, Single Sequence, Two Periods, Four-treatment, Three Parallel Groups Pharmacokinetic Interaction Study of Repeated Oral Doses (Daily or Weekly Regimen) of Rifapentine on ATRIPLAT (Fixed Dose Combination of Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate) Given to HIV+ Patients.
rifapentine (M000473); EFZ EMT TDF

HIV Infections Clinical Trial

University of California, San Francisco - Recruiting 18 years or older.
- SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era.

HIV Infections Clinical Trial

Gilead Sciences - Recruiting 50 years or older.
- A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects.

HIV Clinical Trial

Gilead Sciences - Recruiting 18 years or older.
- A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvadar for Pre-Exposure Prophylaxis (PrEP).

HIV Clinical Trial

Gilead Sciences - Recruiting 18 years or older.
- Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvadar for PrEP: A Case Control Study.

HIV Infection Clinical Trial

Gilead Sciences - Recruiting N/A or older.
- A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication Nested in the Antiretroviral Pregnancy Registry.

Anal Cancer, HIV Infection, or Human Papilloma Virus Infection Clinical Trial using comparison of screening methods; laboratory biomarker analysis; questionnaire administration; quality-of-life assessment

AIDS Malignancy Clinical Trials Consortium - Recruiting 18 years or older.
- Screening HIV-Infected Women for Anal Cancer Precursors.
comparison of screening methods; laboratory biomarker analysis; questionnaire administration; quality-of-life assessment

Human Immunodeficiency Virus (HIV), or Hepatitis C, Chronic Clinical Trial

George Washington University - Recruiting 18 years or older.
- The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System..

HIV-1 Infection Clinical Trial using Placebos of GTU-multiHIV B and LIPO-5 vaccines; GTU-multHIV B vaccine and LIPO-5 vaccine

French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) - Recruiting 18 years to 59 years.
- Evaluation of a Therapeutic Immunization Strategy Associating a DNA Vaccine (GTU-MultiHIV B) Followed by a Lipopeptide Vaccine (LIPO-5) in the Control of Viral Replication Following Antiretroviral Treatment Interruption in HIV-1 Infected Patients With a CD4 Cell Count ò 600/mm3.
Placebos of GTU-multiHIV B and LIPO-5 vaccines; GTU-multHIV B vaccine and LIPO-5 vaccine

HIV Infection Clinical Trial using adherence reinforcement; Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators)

French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) - Recruiting 18 years or older.
- Systematic 'Adherence Intervention' Phase Before Switching to 3rd-line ART in Patients With 2nd-line ART Virologic Failure in Sub-Saharan Africa : a Phase 2b Non-randomized Study..
adherence reinforcement; Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators)

Human Immunodeficiency Virus (HIV), or Acquired Immune Deficiency Clinical Trial using HIV Self-testing with Standard Counseling and Testing (SCT) Confirmation

Columbia University - Recruiting 18 years or older.
- Enhanced HIV Prevention in Serodiscordant Couples Study #3: Feasibility of Home-based Partner Self Testing for HIV.
HIV Self-testing with Standard Counseling and Testing (SCT) Confirmation

Pulmonary Arterial Hypertension, HIV Infection, Congenital Heart Clinical Trial using skin biopsy; Blood Sample

Assistance Publique - H“pitaux de Paris - Recruiting 18 years or older.
- Auto-immunity and Prognosis of Pulmonary Arterial Hypertension.
skin biopsy; Blood Sample

Infection, Human Immunodeficiency Virus Clinical Trial using Dolutegravir/abacavir/lamivudine FDC; Atazanavir; Ritonavir; Tenofovir/emtricitabine FDC

ViiV Healthcare - Recruiting 18 years or older.
- A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine Once Daily Compared to Atazanavir and Ritonavir Plus Tenofovir/Emtricitabine Once Daily in HIV-1 Infected Antiretroviral Therapy Na‹ve Women.
Dolutegravir/abacavir/lamivudine FDC; Atazanavir; Ritonavir; Tenofovir/emtricitabine FDC

HIV-1 Infection, or Pf Subclinical Parasitemia Clinical Trial using Lopinavir/ritonavir; Emtricitabine/tenofovir disoproxil fumarate; Efavirenz; Nevirapine; emtricitabine/tenofovir disoproxil fumarate; trimethoprim/sulfamethoxazole

AIDS Clinical Trials Group - Recruiting 18 years or older.
- An Open-Label, Proof of Concept, Randomized Trial Comparing a LPV/r-Based to an nNRTI-Based Antiretroviral Therapy Regimen for Clearance of Plasmodium Falciparum Subclinical Parasitemia in HIV-infected Adults With CD4+ Counts >200 and <350 Cells/mm3.
Lopinavir/ritonavir; Emtricitabine/tenofovir disoproxil fumarate; Efavirenz; Nevirapine; emtricitabine/tenofovir disoproxil fumarate; trimethoprim/sulfamethoxazole

HIV Infection Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Virologic and Immunologic Evaluation of Lymph Node, Tonsillar, and Intestinal Biopsies, and Bronchoalveolar Lavage Fluid.

AIDS-Related Primary Central Nervous System Lymphoma, or HIV Clinical Trial using Methotrexate; rituximab; antiviral therapy; leucovorin calcium

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- AIDS-Related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate With Rituximab Leucovorin Rescue and Highly Active Antiretroviral Therapy.
Methotrexate; rituximab; antiviral therapy; leucovorin calcium

HIV, or Sexually Transmitted Diseases Clinical Trial using Social Network HIV Testing; Peer Network Intervention

Medical College of Wisconsin - Recruiting 18 years or older.
- High Risk Crack Use Settings and HIV in El Salvador.
Social Network HIV Testing; Peer Network Intervention

HIV Infections Clinical Trial using Emtricitabine (FTC); Tenofovir disoproxil fumarate (TDF); Efavirenz (EFV); Truvada

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 55 years.
- Cellular Pharmacology of Tenofovir and Emtricitabine for HIV Prophylaxis (Cell Prep).
Emtricitabine (FTC); Tenofovir disoproxil fumarate (TDF); Efavirenz (EFV); Truvada

HIV-1 Infection Clinical Trial using Raltegravir; Efavirenz

Taipei Veterans General Hospital, Taiwan - Recruiting 20 years to 60 years.
- An Open Label, Randomized, Parallel Design Estimation Pilot Study to Compare the Efficacy and Safety of Raltegravir-based Versus Efavirenz-based Combination Therapy in Treatment-na‹ve Patients With HIV-1 Infection.
Raltegravir; Efavirenz

Chronic Hepatitis C Infection Clinical Trial using Pegylated Interferon Lambda-1a; Daclatasvir (DCV); Ribasphere (RBV)

Bristol-Myers Squibb - Recruiting 18 years or older.
- Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment na‹ve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV.
Pegylated Interferon Lambda-1a; Daclatasvir (DCV); Ribasphere (RBV)

HIV Clinical Trial using BTWB intervention; Cancer prevention and screening

State University of New York - Downstate Medical Center - Recruiting 18 years or older.
- Barbershop Talk: HIV Prevention for African American Heterosexual Men.
BTWB intervention; Cancer prevention and screening

HIV Clinical Trial using Community leader engagement; Community days; Community Peer Groups

Elizabeth Glaser Pediatric AIDS Foundation - Recruiting 18 years or older.
- Advancing Community Level Action for Improving MCH/PMTCT.
Community leader engagement; Community days; Community Peer Groups

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymph Clinical Trial using leukapheresis; allogeneic hematopoietic stem cell transplantation; autologous hematopoietic stem cell transplantation; peripheral blood stem cell transplantation; laboratory biomarker analysis; DNA analysis; RNA analysis; flow cytometry; reverse transcriptase-polymerase chain reaction; nucleic acid sequencing; protein expression analysis

Fred Hutchinson Cancer Research Center - Recruiting N/A to 75 years.
- Human Immunodeficiency Virus (HIV)-Specific Immune Reconstitution After Hematopoietic Cell Transplant for Treatment of Hematologic Malignancy in Patients Infected With HIV.
leukapheresis; allogeneic hematopoietic stem cell transplantation; autologous hematopoietic stem cell transplantation; peripheral blood stem cell transplantation; laboratory biomarker analysis; DNA analysis; RNA analysis; flow cytometry; reverse transcriptase-polymerase chain reaction; nucleic acid sequencing; protein expression analysis

HIV Infections Clinical Trial using CN54gp140 mixed with GLA-AF

Imperial College London - Recruiting 18 years to 45 years.
- A Phase 1 Open-Labelled Trial to Evaluate the Safety and Immunogenicity of CN54gp140 in HIV-Uninfected, Healthy Volunteers.
CN54gp140 mixed with GLA-AF

HIV/AIDS Clinical Trial using Study Intervention for Retention (APFU)

Columbia University - Recruiting 16 years or older.
- Mother Infant Retention for Health: Evaluation of a Multicomponent Strategy to Link and Retain Newly Identified HIV-infected Pregnant Women and Their Infants Throughout the Antenatal and Post-partum Period.
Study Intervention for Retention (APFU)

HIV, or AIDS Clinical Trial

George Washington University - Recruiting N/A or older.
- Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort.

HIV, or Human Immunodeficiency Virus Clinical Trial using Disulfiram

University of California, San Francisco - Recruiting 18 years or older.
- Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study.
Disulfiram

Human Immunodeficiency Virus Clinical Trial using Raltegravir; Fluconazole; Azithromycin; Albendazole; Isoniazid; Ready to Use Supplementary Food

Medical Research Council - Recruiting 5 years or older.
- Reduction of Early mortALITY in HIV-infected African Adults and Children Starting Antiretroviral Therapy: a Randomised Controlled Trial.
Raltegravir; Fluconazole; Azithromycin; Albendazole; Isoniazid; Ready to Use Supplementary Food

Chronic HIV Infection, or HCV Coinfection Clinical Trial using Fosamprenavir

Fundacion SEIMC-GESIDA - Recruiting 18 years or older.
- Randomized, Controlled, Open Label, Pilot Study to Evaluate Fosamprenavir Activity on Genotype 1 Hepatitis C Virus (HCV) Infection Evolution in Human Immunodeficiency Virus (HIV) Co-infected Subjects With Antiretroviral Treatment Including Fosamprenavir.
Fosamprenavir

HIV, or Hepatitis C Clinical Trial using Intravenous Silibinin (iSIL)

University of Zurich - Recruiting 18 years or older.
- A Phase II, Multi-center, Open-label, Interventional Study to Evaluate the Safety of Intravenous Silibinin (iSIL) and Its Effect on the Hepatitis C Virus Load in Treatment-experienced HCV-HIV Co-infected Individuals With Advanced Liver Fibrosis in the Swiss HIV Cohort Study (SHCS).
Intravenous Silibinin (iSIL)

HIV, Immune Cells (Mucosal and Systemic), or Contraception Clinical Trial using levonorgestrel exposure; DMPA exposure; etonogestrel exposure; IUD insertion; subdermal contraceptive implant insertion

University of Pittsburgh - Recruiting 18 years to 34 years.
- Quantification of Immune Cells in Women Using Contraception.
levonorgestrel exposure; DMPA exposure; etonogestrel exposure; IUD insertion; subdermal contraceptive implant insertion

HIV Infections Clinical Trial using SeV-G(NP) (0.2mL, 2x10^7 CIU); SeV-G(NP) (0.2mL, 2x10^8 CIU); Ad35-GRIN (0.5mL)

International AIDS Vaccine Initiative - Recruiting 18 years to 50 years.
- A Phase I Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety and Immunogenicity of a Sendai HIV Vaccine SeV-G(NP) Given Intranasally and Ad35-GRIN Administered Intramuscularly in Prime-Boost Regimens in HIV-Uninfected, Healthy Adult Volunteers.
SeV-G(NP) (0.2mL, 2x10^7 CIU); SeV-G(NP) (0.2mL, 2x10^8 CIU); Ad35-GRIN (0.5mL)

Assisted-partner Notification Services Clinical Trial using Assisted-partner notification services

University of Washington - Recruiting 18 years or older.
- Assisted Partner Notification to Augment HIV Treatment and Prevention in Kenya.
Assisted-partner notification services

HIV Positive Clinical Trial

QIAGEN Gaithersburg, Inc - Recruiting 18 years to 65 years.
- QuantiFERONr Monitor Test to Evaluate Immune Function in HIV Infected and Uninfected Control Study Subjects.

HIV Infections, or Hepatitis Clinical Trial

Virginia Commonwealth University - Recruiting 18 years to 90 years.
- HIV-HCV Coinfection: Impact of Immune Dysfunction.

HIV-2 Infection Clinical Trial using emtricitabine / tenofovir disoproxil fumarate / raltegravir .

French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) - Recruiting 18 years or older.
- ANRS 159 VIH-2 : Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients.
emtricitabine / tenofovir disoproxil fumarate / raltegravir .

HIV, Tuberculosis, or Pediatric Clinical Trial using Development of a diagnosis algorithm

French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) - Recruiting N/A to 13 years.
- Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam) and Africa (Burkina Faso, Cameroon) ANRS 12229 PAANTHER 01 (Pediatric Asian African Network for Tuberculosis and HIV Research).
Development of a diagnosis algorithm

Adherence to HIV Treatment and Medication Clinical Trial using IMB Gaming Adherence Intervention; Enhanced treatment as usual

Rhode Island Hospital - Recruiting 14 years to 26 years.
- A Pilot Gaming Adherence Program for Youth Living With HIV.
IMB Gaming Adherence Intervention; Enhanced treatment as usual

Human Immunodeficiency Virus Clinical Trial using TwHF; placebo treatment

Beijing 302 Hospital - Recruiting 18 years to 60 years.
- Phase 1/2 Study of Tripterygium Wilfordii Hook F (TwHF) Treatment for Evaluation the Efficacy and Safety in Immune Non-responders With HIV-1 Infection.
TwHF; placebo treatment

HIV Infection Clinical Trial

Bristol-Myers Squibb - Recruiting N/A to 17 years.
- Post-marketing Safety Surveillance Program in HIV-infected Children Exposed to Atazanavir in Europe.

HIV, or Sexually Transmitted Infections Clinical Trial using Connect 'n Unite; Wellness Promotion

Columbia University - Recruiting 18 years or older.
- Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM.
Connect 'n Unite; Wellness Promotion

HIV, Acquired Immunodeficiency Syndrome, Alcoholism, Alcoholic In Clinical Trial using Motivational Interviewing; Email Feedback; Usual Care

University of California, San Francisco - Recruiting 18 years or older.
- Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients.
Motivational Interviewing; Email Feedback; Usual Care

HIV Clinical Trial using (FDC) ELV/COBI/FTC/TDF

Duke University - Recruiting 18 years to 75 years.
- Treatment of Acute HIV Infection With the Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate, A Pilot Study of Response to Therapy and HIV Pathogenesis.
(FDC) ELV/COBI/FTC/TDF

Sexually Transmitted Diseases, Pregnancy, or HIV Infections Clinical Trial using HIV, STI and Pregnancy Prevention Curriculum; Control Curricula

The University of Texas Health Science Center, Houston - Recruiting 12 years to 14 years.
- It's Your Game...Keep It Real for American Indian/Alaska Native Youth: Innovative Approaches to Prevent Teen Pregnancy Among Underserved Populations.
HIV, STI and Pregnancy Prevention Curriculum; Control Curricula

HIV, or Addiction Clinical Trial using Integrated methadone and antiretroviral therapy (iMART) clinic

Johns Hopkins University - Recruiting 18 years or older.
- Seek, Test, Treat Strategies for Vietnamese Drug Users: A Randomized Controlled Trial.
Integrated methadone and antiretroviral therapy (iMART) clinic

HIV, Herpes Simplex 2, Hepatitis C, Hepatitis B, or Chagas Diseas Clinical Trial using HIV Counseling and Testing; Blood Donation

Blood Systems Research Institute - Recruiting 18 years to 65 years.
- Improving Blood Safety and HIV Testing in Brazil: a Randomized Controlled Trial.
HIV Counseling and Testing; Blood Donation

Pregnancy in Adolescence, or HIV Clinical Trial using Making Proud Choices; Making Proud Choices AND Getting To Outcomes

RAND - Recruiting 10 years to 14 years.
- Enhancing Quality Interventions Promoting Healthy Sexuality.
Making Proud Choices; Making Proud Choices AND Getting To Outcomes

HIV Dementia Clinical Trial using Atorvastatin (generic Lipitor); placebo

University of Pennsylvania - Recruiting 18 years to 60 years.
- .
Atorvastatin (generic Lipitor); placebo

HIV Clinical Trial using Peer Education Randomized Controlled Trial for Black MSM for VCT and Prevention

Johns Hopkins Bloomberg School of Public Health - Recruiting 18 years or older.
- A Randomized Controlled Trial to Train Black MSM as Peer Health Educators for HIV Testing and Prevention.
Peer Education Randomized Controlled Trial for Black MSM for VCT and Prevention

HIV Infection Clinical Trial using antiretroviral treatment

Hospital Clinic of Barcelona - Recruiting 18 years or older.
- Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy Instead of a Triple Therapy That Includes Lopinavir/Ritonavir and Lamivudine or Emtricitabine in HIV Patients With Viral Suppression: Controlled Clinical Trial, Open Label, Randomized, of 48 Weeks of Follow-up.
antiretroviral treatment

Hazardous Alcohol Use, Binge Drinking, High Risk Sexual Behaviors Clinical Trial using Computerized brief alcohol intervention with IVR booster calls; Computer delivered brief alcohol intervention; Attention Control

Johns Hopkins University - Recruiting 18 years or older.
- Computerized BI for Binge Drinking HIV At-Risk and Infected African-American Women.
Computerized brief alcohol intervention with IVR booster calls; Computer delivered brief alcohol intervention; Attention Control

HIV Disease Clinical Trial using à1 Proteinase Inhibitor; Placebo

AIDS Community Research Initiative of America - Recruiting 18 years to 65 years.
- A Double Blind, Randomized Trial to Evaluate the Safety and Efficacy of 8 Weekly Doses of Prolastinr-C (à1Proteinase Inhibitor, à1PI) in Human Immunodeficiency Virus-Infected Subjects Who Are 18 to 65 Years of Age and Who Are on Antiretroviral Therapy.
à1 Proteinase Inhibitor; Placebo

HIV Infections Clinical Trial using Isentressr; Celsentrir

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer - Recruiting 18 years or older.
- IMPACT OF THERAPY INTENSIFICATION BY AN INTEGRASE INHIBITOR +/- CCR5 INHIBITOR ON THE LYMPHOID RESERVOIR FOR HIV-1 IN CHRONICALLY INFECTED PATIENTS.
Isentressr; Celsentrir

Tuberculosis Clinical Trial using Urine LAM strip test

University of Cape Town - Recruiting 18 years or older.
- A Randomized Controlled Trial to Evaluate the Impact of Using a Point-of-care Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected Patients in Resource-poor Settings.
Urine LAM strip test

Stigma Clinical Trial using MMT CARE

University of California, Los Angeles - Recruiting 18 years or older.
- Methadone Maintenance Treatment (MMT) Care for HIV Prevention: A Randomized Controlled Trial (MMT2).
MMT CARE

HIV Infections Clinical Trial

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 30 years to 55 years.
- Women's Interagency HIV Study (WIHS).

Substance-related Disorders, or HIV Risk Behavior Clinical Trial using Therapeutic Workplace; Methadone; Buprenorphine

Johns Hopkins University - Recruiting 18 years to 65 years.
- Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution.
Therapeutic Workplace; Methadone; Buprenorphine

High Triglyceride Level, or HIV Infection Clinical Trial using Lovaza

Tufts University - Recruiting 18 years or older.
- The Impact of Omega Three Fatty Acids on Vascular Function in HIV.
Lovaza

T Cell Response to Asthma in HIV-infected Patients Before and Aft Clinical Trial using HAART

The HIV Netherlands Australia Thailand Research Collaboration - Recruiting 2 years to 18 years.
- Allergen Specific T Effector and T Regulatory Cell Response to Common Aeroallergens Following Immune Restoration in HIV-infected Children.
HAART

Nicotine Dependence, Symptoms of Anxiety, or HIV Clinical Trial using Integrated cognitive-behavioral therapy for smoking cessation and anxiety

Massachusetts General Hospital - Recruiting 18 years to 65 years.
- Integrated Treatment for Smoking Cessation & Anxiety in People With HIV Phase 1.
Integrated cognitive-behavioral therapy for smoking cessation and anxiety

HIV-associated Hodgkin Lymphoma Clinical Trial using Doxorubicin; Bleomycin; Vinblastine; Dacarbazine; Etoposide; Cyclophosphamide; Vincristine; Procarbazine; Prednisone

Harlachinger Krebshilfe e.V. - Recruiting 18 years to 75 years.
- A Prospective Multicenter Study on HIV-associated Hodgkin Lymphoma.
Doxorubicin; Bleomycin; Vinblastine; Dacarbazine; Etoposide; Cyclophosphamide; Vincristine; Procarbazine; Prednisone

HIV Clinical Trial using Raltegravir

Imperial College London - Recruiting 60 years or older.
- An Open Label Study to Investigate the Safety, Pharmacokinetic Profile and Efficacy of Raltegravir in HIV-infected Patients at Least 60 Years of Age.
Raltegravir

HIV Infection, or Pulmonary TB Clinical Trial using ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)

Tuberculosis Research Centre, India - Recruiting 18 years or older.
- A Randomized Controlled Clinical Trial Comparing Daily Vs. Intermittent 6 - Month Short Course Chemotherapy in Reducing Failures & Emergence of Acquired Rifampicin Resistance (ARR) in Patients With HIV and Pulmonary Tuberculosis.
ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)

HIV, AIDS, Opioid Dependence, or Drug Dependence Clinical Trial using Depot Naltrexone

Yale University - Recruiting 18 years or older.
- Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations.
Depot Naltrexone

HIV Infections, or Hepatitis C Clinical Trial using Raltegravir; Atazanavir/Ritonavir

St. James's Hospital, Ireland - Recruiting 18 years or older.
- An Open-label, Randomised Pilot Study Comparing the Efficacy, Safety and Tolerability of Raltegravir With Protease Inhibitor-based Therapy in Treatment-na‹ve, HIV/Hepatitis C Co-infected Injecting Drug Users Receiving Methadone.
Raltegravir; Atazanavir/Ritonavir

HIV-1, or HIV Infections Clinical Trial using MVA.HIVA

Medical Research Council - Recruiting N/A to 3 Days.
- An Open Randomized Phase I/II Study Evaluating Safety and Immunogenicity of a Candidate HIV-1 Vaccine, MVA.HIVA, Administered to Healthy Infants Born to HIV-1-infected Mothers.
MVA.HIVA

HIV Infection Clinical Trial

Istituto Superiore di Sanita - Recruiting 18 years to 45 years.
- A Multicentre, Observational, Cross-sectional Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients in Selected Areas of Gauteng and Eastern Cape.

Hepatitis C, Chronic, or HIV Infection Clinical Trial using Adherence questionnaire

Fundacion IMIM - Recruiting 18 years or older.
- Development and Validation of a Questionnaire Measuring Treatment Adherence in Patients With Hepatitis C.
Adherence questionnaire

HIV Infections Clinical Trial using generic FDC of TDF/3TC/EFV

The HIV Netherlands Australia Thailand Research Collaboration - Recruiting 18 years or older.
- Generic Fixed Dose Combination (FDC) of Tenofovir(TDF) /Lamivudine(3TC)/Efavirenz (EFV) Tablets 300/300/600 mg.
generic FDC of TDF/3TC/EFV

Tuberculosis, or HIV Infections Clinical Trial using Emtricitabine/tenofovir/efavirenz

African Poverty Related Infection Oriented Research Initiative - Recruiting 18 years to 65 years.
- The Pharmacokinetics of Co-formulated Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Smear-positive Pulmonary Tuberculosis in the Kilimanjaro Region, Tanzania.
Emtricitabine/tenofovir/efavirenz

HIV Infections, or Acquired Immunodeficiency Syndrome Clinical Trial using Structured Ecosystems Therapy (SET)

National Institute of Mental Health (NIMH) - Recruiting 18 years or older.
- Ecosystems Therapy for Men Reintegrating Into Their Family.
Structured Ecosystems Therapy (SET)

HIV, or HIV Infections Clinical Trial using Darunavir, Ritonavir, Truvada; Darunavir, Ritonavir and Etravirine

Imperial College London - Recruiting 18 years or older.
- A Randomised, Open Label, Prospective Study to Assess Two Different Therapeutic Strategies Following First Treatment Failure in HIV-1 Infected Subjects.
Darunavir, Ritonavir, Truvada; Darunavir, Ritonavir and Etravirine

HIV, or Hepatitis C Clinical Trial using Motivational interviewing; Educational intervention

Universit‚ de Sherbrooke - Recruiting 16 years or older.
- Effects of a Brief Motivational Intervention on Risky Injection Practices Among Injecting Drug Users.
Motivational interviewing; Educational intervention

Kaposi's Sarcoma Clinical Trial using Indinavir in association with Vinblastina +/- Bleomicina

Istituto Superiore di Sanita - Recruiting 18 years or older.
- Phase II Trial for the Treatment of Advanced Classical Kaposi's Sarcoma With the HIV Protease Inhibitor Indinavir in Combination With Chemotherapy.
Indinavir in association with Vinblastina +/- Bleomicina

HIV Infections Clinical Trial using Pioglitazone; Observation

University of Texas Southwestern Medical Center - Recruiting 18 years or older.
- Human Immunodeficiency Virus Acquired Lipodystrophy (HAL) Classification, Measurement, & Fat Response to a Thiazolidinedione (TZD) Challenge in Differing Adult Phenotypic Presentations.
Pioglitazone; Observation

HIV, Lung, or HIV Infections Clinical Trial using Smoking Cessation

National Heart, Lung, and Blood Institute (NHLBI) - Recruiting 18 years or older.
- Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV).
Smoking Cessation

HIV, or HIV Infections Clinical Trial using MISC training for primary caregivers

Makerere University - Recruiting 16 Months to 6 years.
- Cognitive and Psychosocial Benefits of Caregiver Training for Ugandan HIV Children.
MISC training for primary caregivers

HIV Infections Clinical Trial using Raltegravir (MK-0518)

University of Pittsburgh - Recruiting 18 years or older.
- Investigating the Source of HIV-1 Viremia in Patients on Antiretroviral Therapy Through Intensification With MK-0518.
Raltegravir (MK-0518)

HIV Infections Clinical Trial

National Taiwan University Hospital - Recruiting 20 years to 60 years.
- The Detection of Drug-Resistant HIV-1 in Taiwan.

HIV Infections Clinical Trial using etanercept

University of Wisconsin, Madison - Recruiting 18 years or older.
- A Pilot Study to Examine the Feasibility and Effect on Tumor Necrosis Factor (TNF) Inhibition on HIV Disease.
etanercept

Infant, Newborn, Diseases, Sepsis, or Puerperal Infection Clinical Trial using Chlorhexidine; Birth canal wipe; sterile water external genital wipe

Centers for Disease Control and Prevention - Recruiting 15 years or older.
- Preventing Serious Neonatal and Maternal Peripartum Infections in Developing Country Settings With a High Prevalence of HIV Infection: Assessment of the Disease Burden and Evaluation of an Affordable Intervention in Soweto, South Africa.
Chlorhexidine; Birth canal wipe; sterile water external genital wipe

HIV Infections Clinical Trial

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 60 years.
- Evaluation of HIV-Specific Immunological and Virological Responses of HIV-1 Multiply-Exposed Seronegative Individuals.

Vitamin D Deficiency, or HIV Infections Clinical Trial using colecalciferol

Radboud University - Recruiting 18 years or older.
- The Prevalence of Vitamin D Deficiency and Effects of Vitamin D Supplementation in HIV-1 Infected Patients.
colecalciferol

HIV Infections Clinical Trial

Bayside Health - Recruiting N/A or older.
- Role of Naive T-Cells in the Pathogenesis of T-Cell Decline and Long Term Persistence of HIV.

Opiate Dependence, or HIV Infections Clinical Trial using Integrating drug treatment into HIV services

Organization to Achieve Solutions in Substance Abuse (OASIS) - Recruiting 18 years to 85 years.
- SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model.
Integrating drug treatment into HIV services

HIV Infection, or AIDS Clinical Trial using once daily minimum 3-drug regimen of anti-retroviral medications

407 Doctors - Recruiting 18 years or older.
- A Randomised, Multi-Centre, Open-Label Study in Well-Controlled Treatment-Experienced HIV-Infected Patients to Assess Compliance With a Once-Daily Regimen of Lamivudine, Efavirenz and Didanosine Versus Continuation of Current Anti-Retroviral Regimen Delivered at Least Twice Daily.
once daily minimum 3-drug regimen of anti-retroviral medications